[go: up one dir, main page]

EE200200298A - Substituted phthalocyanines and their parent compounds, process for their preparation and use, pharmaceutical composition and material - Google Patents

Substituted phthalocyanines and their parent compounds, process for their preparation and use, pharmaceutical composition and material

Info

Publication number
EE200200298A
EE200200298A EEP200200298A EEP200200298A EE200200298A EE 200200298 A EE200200298 A EE 200200298A EE P200200298 A EEP200200298 A EE P200200298A EE P200200298 A EEP200200298 A EE P200200298A EE 200200298 A EE200200298 A EE 200200298A
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical composition
parent compounds
substituted phthalocyanines
phthalocyanines
Prior art date
Application number
EEP200200298A
Other languages
Estonian (et)
Inventor
John Cook Michael
James Heeney Martin
Original Assignee
Gentian As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929064.5A external-priority patent/GB9929064D0/en
Priority claimed from GBGB0025817.8A external-priority patent/GB0025817D0/en
Application filed by Gentian As filed Critical Gentian As
Publication of EE200200298A publication Critical patent/EE200200298A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00Porphines; Azaporphines
    • C09B47/04Phthalocyanines abbreviation: Pc
    • C09B47/045Special non-pigmentary uses, e.g. catalyst, photosensitisers of phthalocyanine dyes or pigments
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00Porphines; Azaporphines
    • C09B47/04Phthalocyanines abbreviation: Pc
    • C09B47/06Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00Porphines; Azaporphines
    • C09B47/04Phthalocyanines abbreviation: Pc
    • C09B47/06Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide
    • C09B47/067Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile
    • C09B47/0673Preparation from carboxylic acids or derivatives thereof, e.g. anhydrides, amides, mononitriles, phthalimide, o-cyanobenzamide from phthalodinitriles naphthalenedinitriles, aromatic dinitriles prepared in situ, hydrogenated phthalodinitrile having alkyl radicals linked directly to the Pc skeleton; having carbocyclic groups linked directly to the skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Nanotechnology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200200298A 1999-12-08 2000-12-08 Substituted phthalocyanines and their parent compounds, process for their preparation and use, pharmaceutical composition and material EE200200298A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9929064.5A GB9929064D0 (en) 1999-12-08 1999-12-08 Substituted phthalocyanines and their precursors
GB0012348A GB0012348D0 (en) 1999-12-08 2000-05-22 Substituted phthalocyanines and their precursors
GBGB0025817.8A GB0025817D0 (en) 1999-12-08 2000-10-20 Substituted phthalocyanines and their precursors
PCT/GB2000/004708 WO2001042368A1 (en) 1999-12-08 2000-12-08 Substituted phthalocyanines and their precursors

Publications (1)

Publication Number Publication Date
EE200200298A true EE200200298A (en) 2003-08-15

Family

ID=27255732

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200298A EE200200298A (en) 1999-12-08 2000-12-08 Substituted phthalocyanines and their parent compounds, process for their preparation and use, pharmaceutical composition and material

Country Status (10)

Country Link
EP (1) EP1238016A1 (en)
JP (1) JP2003516421A (en)
AU (1) AU2192201A (en)
CA (1) CA2394891A1 (en)
CZ (1) CZ20021974A3 (en)
EE (1) EE200200298A (en)
HU (1) HUP0301099A3 (en)
NO (1) NO20022663L (en)
PL (1) PL355851A1 (en)
WO (1) WO2001042368A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002341034B2 (en) * 2001-03-21 2007-06-14 Molteni Therapeutics S.R.L. Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
US7091373B2 (en) 2002-03-18 2006-08-15 Sumitomo Chemical Company, Limited Production method for biarylalanine
CN100415715C (en) * 2003-02-11 2008-09-03 杜锡光 Superphthalocyanine compound with six isoindole structural subunits in porphyrazine ring, synthesis method and application
CA2525447C (en) * 2003-05-14 2013-08-06 Universite De Sherbrooke Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine
JP4809657B2 (en) * 2005-09-29 2011-11-09 富士フイルム株式会社 Naphthalocyanine dye and method for producing the same
JP4942351B2 (en) * 2006-01-31 2012-05-30 独立行政法人科学技術振興機構 Photodynamic therapy anticancer agent
JP5296355B2 (en) * 2007-09-11 2013-09-25 株式会社日本触媒 Aryl group-containing phthalocyanine compound, method for producing the same, and compound
US8168359B2 (en) * 2008-03-10 2012-05-01 Xerox Corporation Nanosized particles of phthalocyanine pigments
CZ303612B6 (en) * 2010-08-19 2013-01-09 Výzkumný ústav organických syntéz a.s. Compound based on phthalocyanine derivative for photodynamic inactivation of both gram-positive and gram-negative bacteria as well as pathogenic yeast, and use of this compound
JP2012167189A (en) * 2011-02-14 2012-09-06 Aisin Seiki Co Ltd Phthalocyanine derivative, method for producing the same, and dye-sensitized solar cell
JP2013193956A (en) * 2012-03-15 2013-09-30 Saitama Univ Tetrakis-trialkyl or phenylsilylethynyl-substituted phthalocyanine, and method for producing the same
JP6278386B2 (en) * 2013-11-06 2018-02-14 国立研究開発法人産業技術総合研究所 Phthalocyanine compounds and organic semiconductor materials
CN103864645B (en) * 2013-12-30 2016-08-17 常州大学 A kind of two replacement perfluoroalkyl phthalonitrile compound and preparation method thereof
CN104016995A (en) * 2014-06-26 2014-09-03 常州大学 Octa-substituted perfluoroalkyl cobalt phthalocyanine compound and preparation method thereof
JP6608187B2 (en) * 2015-06-22 2019-11-20 山本化成株式会社 Sensitizing dye, semiconductor electrode, photoelectric conversion element, and dye-sensitized solar cell
TWI705061B (en) 2016-08-24 2020-09-21 德商賽諾拉公司 Organic molecules, especially for use in organic optoelectronic devices
CN108017650A (en) * 2017-03-08 2018-05-11 先尼科化工(上海)有限公司 A kind of phthalocyanine compound for optical filter and its preparation method and application method
CN110494501B (en) * 2017-04-07 2022-04-19 山本化成株式会社 Phthalocyanine-based compound and use thereof
EP3611175B1 (en) * 2017-04-07 2022-02-09 Yamamoto Chemicals, Inc. Naphthalocyanine compound, method for producing same, and use thereof
JP6922361B2 (en) * 2017-04-07 2021-08-18 Jsr株式会社 Composition for solid-state image sensor, infrared shielding film and solid-state image sensor
WO2020071470A1 (en) * 2018-10-05 2020-04-09 山本化成株式会社 Phthalocyanine compound and use thereof
CN112279856B (en) * 2019-07-24 2021-09-17 南方科技大学 Non-peripherally-substituted soluble metal phthalocyanine, synthesis method and application thereof, and perovskite solar cell
CN112014383B (en) * 2020-06-30 2024-03-29 杜旭忠 Photosensitizer for homogeneous chemiluminescence and preparation method and application thereof
KR20230044432A (en) * 2020-07-31 2023-04-04 스미또모 가가꾸 가부시키가이샤 compound
CN112812299B (en) * 2020-12-31 2022-03-29 四川大学 Phthalonitrile and amino acid cyclic peptide copolymer resin and preparation method thereof
JPWO2022196089A1 (en) * 2021-03-15 2022-09-22
EP4574911A1 (en) 2023-12-22 2025-06-25 Holland Colours N. V. Bio-sourced phthalocyanine complex, preparation and use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155780B1 (en) * 1984-03-21 1990-03-28 Imperial Chemical Industries Plc Infra-red absorber
GB8431446D0 (en) * 1984-12-13 1985-01-23 Secr Defence Alkoxyphthalocyanines
GB8619238D0 (en) * 1986-08-06 1986-09-17 Ici Plc Organic photoconductor
JP2613647B2 (en) * 1987-02-13 1997-05-28 イギリス国 Substituted phthalocyanines
JPH0730300B2 (en) * 1988-04-01 1995-04-05 三井東圧化学株式会社 Alkyl phthalocyanine near infrared absorber and display / recording material using the same
CA2005520A1 (en) * 1988-12-15 1990-06-15 Hisato Itoh Near infrared absorbent and display/recording materials prepared by using same
JPH07103093B2 (en) * 1989-01-12 1995-11-08 三井東圧化学株式会社 Phthalonitrile-based compound and method for producing the same
DE69228502T2 (en) * 1991-06-19 1999-08-12 Mitsui Chemicals, Inc., Tokio/Tokyo Phthalocyanine compounds and their use
ATE174942T1 (en) * 1991-11-08 1999-01-15 Eastman Chem Co THERMOPLASTIC POLYMER COMPOSITION CONTAINING ONE OR MORE MONOMERIC NEAR INFAROT FLUORESCENT COMPOUNDS MIXED THEREIN
GB9317881D0 (en) * 1993-08-27 1993-10-13 Secr Defence Photosensitizers
US5456998A (en) * 1994-04-26 1995-10-10 Xerox Corporation Photoconductive imaging members containing alkoxy-bridged metallophthalocyanine dimers
JPH0892190A (en) * 1994-09-26 1996-04-09 Kanto Chem Co Inc Cyanobiphenyl derivative and liquid crystal composition containing the derivative
GB9613476D0 (en) * 1996-06-27 1996-08-28 British Polythene Ltd Improvements in or relating to films and/or coatings
IT1294325B1 (en) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali ZINC-PHTHALOCYANINS AND THEIR CONJUGATES, PREPARATION AND USE IN PHOTODYNAMIC THERAPY AND AS DIAGNOSTIC
US6511971B1 (en) * 1998-10-13 2003-01-28 Brown University Research Foundation Substituted perhalogenated phthalocyanines

Also Published As

Publication number Publication date
HUP0301099A3 (en) 2003-11-28
EP1238016A1 (en) 2002-09-11
NO20022663D0 (en) 2002-06-05
WO2001042368A1 (en) 2001-06-14
AU2192201A (en) 2001-06-18
CZ20021974A3 (en) 2002-11-13
CA2394891A1 (en) 2001-06-14
JP2003516421A (en) 2003-05-13
HUP0301099A2 (en) 2003-08-28
NO20022663L (en) 2002-08-08
PL355851A1 (en) 2004-05-31

Similar Documents

Publication Publication Date Title
EE200200298A (en) Substituted phthalocyanines and their parent compounds, process for their preparation and use, pharmaceutical composition and material
EE200100684A (en) Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions
EE200100431A (en) 16-haloepothilone derivatives, process for their preparation and pharmaceutical use
EE200200017A (en) Quinuclidine derivatives, process for their preparation, intermediates, pharmaceutical composition and their use
EE200200487A (en) Azetidine derivatives, processes for their preparation and pharmaceutical composition
EE200200095A (en) Sulfonylcarboxamide derivatives, their uses, pharmaceuticals and process for their preparation
EE05214B1 (en) Polyol-IFN-β conjugate, process for its preparation and pharmaceutical composition
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
EE04399B1 (en) Spiroazabicyclic Heterocyclic Compounds, Process for their Preparation, Pharmaceutical Compositions Containing Them and Their Use in Therapy
HUP0203183A3 (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
EE200000468A (en) The compounds, their use and the pharmaceutical composition
HUP0203136A3 (en) Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203548A3 (en) New spirooxindole derivatives, process for their preparation, pharmaceutical compositions containing them and their use
FI973148A7 (en) Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
EE200200409A (en) 1,3-Dihydro-2H-indol-2-one derivatives, process for their preparation and pharmaceutical compositions containing them
EE200000596A (en) Thienylazolylalkoxyethanamine derivatives, process and their preparation, pharmaceutical composition and use, and intermediate and process for their preparation
NO20016038D0 (en) Benzene derivatives, processes for their preparation and pharmaceutical compositions containing the same
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EE9900112A (en) 2-Cyanoiminoimidazole derivatives, process for their preparation, use and pharmaceutical compositions
EE04346B1 (en) Azoles, process for their preparation, use and pharmaceutical composition
EE200000767A (en) Substituted triazolopyridazine derivative, process for its preparation and use, and pharmaceutical composition
FI956278L (en) Substituted 4-phenylthiazole derivatives, process for their preparation and pharmaceutical compositions containing them
FI960316A7 (en) Oxathiolanes, process for their preparation and pharmaceutical compositions containing them
EE03996B1 (en) Pharmaceutical compositions, process for their preparation and use
FI955085L (en) Novel diosmetin compounds, process for their preparation and pharmaceutical compositions containing them